Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First NDA filing for Prevatac expected to be delayed

Feb. 2, 1999

Ilex Oncology adds Canadian trial site to intoplicine development

Feb. 2, 1999

CPMP recommends approval of Paxene for AIDS-related KS

Feb. 1, 1999

Patent covering second-generation taxanes issues to Xechem

Jan. 29, 1999

Proteasome inhibitors may have potential in refractory CLL

Jan. 29, 1999

Temodal receives E.U. approval for recurrent gliobastoma multiforme

Jan. 29, 1999

Newly patented antiproliferative agents selectively inhibit protein farnesyltransferase

Jan. 29, 1999

Structurally novel dimeric steroid with cytotoxic activity isolated from marine sponge

Jan. 28, 1999

Orally active inhibitors of tumor neovascularization described by Mercian

Jan. 28, 1999

Ilex, Lilly sign agreement for novel antitumor diarylsulfonylurea

Jan. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...